Armando Anido insider trades: Zynerba Pharmaceuticals (ZYNE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Armando reports to the SEC
and 2 more companies
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | ZYNE | ↓ Sell | 17,830 | $1.33 | $24K | Direct | Sep 14, 2023 (1d) |
| Jan 23, 2023 | ZYNE | ↓ Sell | 35,453 | $0.60 | $21K | Direct | Jan 25, 2023 (2d) |
| Jul 19, 2022 | ZYNE | ↓ Sell | 11,899 | $1.10 | $13K | Direct | Jul 20, 2022 (1d) |
| Dec 21, 2020 | SCYX | ↑ Buy | 5,000 | $6.25 | $31K | Direct | Dec 23, 2020 (2d) |
| Aug 6, 2018 | ZYNE | ↑ Buy | 15,000 | $5.96 | $89K | Direct | Aug 7, 2018 (1d) |
| May 15, 2017 | ZYNE | ↑ Buy | 5,000 | $19.70 | $99K | Direct | May 16, 2017 (1d) |
| Oct 7, 2011 | AUXL | ↓ Sell | 5,275 | $14.23 | $75K | Direct | Oct 11, 2011 (4d) |
| Jul 8, 2011 | AUXL | ↓ Sell | 5,275 | $20.30 | $107K | Direct | Jul 12, 2011 (4d) |
| Mar 8, 2011 | AUXL | ↓ Sell | 10,555 | $23.02 | $243K | Direct | Mar 9, 2011 (1d) |
| Jan 10, 2011 | AUXL | ↓ Sell | 10,555 | $23.22 | $245K | Direct | Jan 12, 2011 (2d) |
| Apr 12, 2010 | AUXL | ↓ Sell | 30,000 | $33.07 | $992K | Direct | Apr 14, 2010 (2d) |
| Jun 26, 2009 | AUXL | ↓ Sell | 30,000 | $30.30 | $909K | Direct | Jun 30, 2009 (4d) |
| Mar 16, 2009 | AUXL | ↓ Sell | 30,000 | $29.73 | $892K | Direct | Mar 17, 2009 (1d) |
| Feb 3, 2006 | MEDI | ↓ Sell | 11,562 | $32.69 | $378K | Direct | Feb 7, 2006 (4d) |
| Nov 8, 2005 | MEDI | ↓ Sell | 40,625 | $34.90 | $1.4M | Direct | Nov 9, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Armando Anido's insider trades
Armando Anido is Chairman & Chief Exec. Officer at Zynerba Pharmaceuticals (ZYNE). Since Nov 8, 2005, Armando has reported 3 open-market purchases worth $219K and 12 sales worth $5.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (48 filings), option exercises (10 filings), shares withheld for taxes (8 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZYNE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.